Portal de Periódicos da CAPES

Defining clinical improvement in rheumatoid arthritis

1991; Wiley; Volume: 34; Issue: 4 Linguagem: Inglês

10.1002/art.1780340420

1529-0131

David T. Felson, Robert F. Meenan,

Innovations in Medical Education

Arthritis & RheumatismVolume 34, Issue 4 p. 499-500 LettersFree to Read Defining clinical improvement in rheumatoid arthritis David T. Felson MD, MPH, David T. Felson MD, MPH Boston University School of Medicine Boston, MassachusettsSearch for more papers by this authorRobert F. Meenan MD, MPH, Robert F. Meenan MD, MPH Boston University School of Medicine Boston, MassachusettsSearch for more papers by this author David T. Felson MD, MPH, David T. Felson MD, MPH Boston University School of Medicine Boston, MassachusettsSearch for more papers by this authorRobert F. Meenan MD, MPH, Robert F. Meenan MD, MPH Boston University School of Medicine Boston, MassachusettsSearch for more papers by this author First published: April 1991 https://doi.org/10.1002/art.1780340420Citations: 5AboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onEmailFacebookTwitterLinkedInRedditWechat No abstract is available for this article. References 1 Paulus HE, Egger MJ, Ward JR, Williams HJ, and the Cooperative Systematic Studies of Rheumatic Diseases Group: Analysis of improvement in individual rheumatoid arthritis patients treated with disease-modifying antirheumatic drugs, based on the findings in patients treated with placebo. Arthritis Rheum 33: 477–484, 1990 2 Pocock SJ: The value of placebo controls, Clinical Trials: A Practical Approach. Edited by SJ Pocock. Chichester, John Wiley & Sons, 1983 3 Weinblatt M: Methotrexate, Textbook of Rheumatology. Third edition. Edited by WN Kelley, ED Harris, S Ruddy, CB Sledge. Philadelphia, WB Saunders, 1989 4 Ward JR, Williams HJ, Boyce E, Egger MJ, Reading JC, Samuelson CO: Comparison of auranofin, gold sodium thiomalate and placebo in the treatment of rheumatoid arthritis: subsets of response. Am J Med 75 (suppl): 133–137, 1983 5 Anderson JJ, Felson DT, Meenan RF, Williams HJ: Which traditional measures should be used in rheumatoid arthritis clinical trials? Arthritis Rheum 32: 1094–1099, 1989 6 Anderson JJ, Firschein HE, Meenan RF: Sensitivity of a health status measure to short-term clinical changes in arthritis. Arthritis Rheum 32: 844–850, 1989 Citing Literature Volume34, Issue4April 1991Pages 499-500 ReferencesRelatedInformation